Red Tree Management
CTNM icon

Red Tree Management’s Contineum Therapeutics CTNM Stock Holding History

Red Tree Management’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.56M Hold
638,158
– – 7.34% 3
2026
Q2 		$10.5M Hold
638,158
– – 7.1% 3
2026
Q1 		$8.33M Hold
638,158
– – 7.45% 3
2025
Q4 		$7.29M Hold
638,158
– – 6.69% 3
2025
Q3 		$7.5M Hold
638,158
– – 9.04% 3
2025
Q2 		$2.53M Hold
638,158
– – 3.46% 3
2025
Q1 		$4.45M Hold
638,158
– – 4.81% 4
2024
Q4 		$9.35M Buy
+638,158
New +$10.1M 6.15% 4

Other funds holding CTNM

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Torren Management
Torren Management San Diego, California $201M AUM 16.25% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Red Tree Management's CTNM Position: Q3 2026 in Review

Red Tree Management held its Contineum Therapeutics (CTNM) position steady in Q3 2026 at 638,158 shares worth $8.56M. The position accounts for 7.34% of the portfolio, ranked #3.

Red Tree Management first reported a position in CTNM in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.5M in Q2 2026. 15 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Red Tree Management held 638,158 shares of Contineum Therapeutics worth $8.56M as of Q3 2026.
  • Red Tree Management left its Contineum Therapeutics share count unchanged in Q3 2026.
  • Contineum Therapeutics made up 7.34% of Red Tree Management's portfolio in Q3 2026, its #3 holding.
  • Red Tree Management first reported a position in Contineum Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • Red Tree Management's Contineum Therapeutics position peaked at $10.5M in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Red Tree Management's 13F filing for Q3 2026, filed 15 Oct 2026.